abstract |
The present invention relates to an anti-RhD monoclonal antibody, which is a tetrameric IgG1 immunoglobulin consisting of two heavy and two light chains, wherein the heavy chain comprises the amino acid sequence of SEQ ID NO: 2 having a phenylalanine residue at position 68, The light chain comprises the amino acid sequence of SEQ ID NO. |